A citation-based method for searching scientific literature

Jessica R Blount, Sean L Johnson, Sokol V Todi. Front Cell Dev Biol 2020
Times Cited: 5







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Polyubiquitin Drives the Molecular Interactions of the NF-κB Essential Modulator (NEMO) by Allosteric Regulation.
Dragana A M Catici, James E Horne, Grace E Cooper, Christopher R Pudney. J Biol Chem 2015
16
40

Direct activation of protein kinases by unanchored polyubiquitin chains.
Zong-Ping Xia, Lijun Sun, Xiang Chen, Gabriel Pineda, Xiaomo Jiang, Anirban Adhikari, Wenwen Zeng, Zhijian J Chen. Nature 2009
400
40


Mucin 2 (MUC2) promoter characterization: an overview.
Melissa Shizue de A Yamashita, Eduardo O Melo. Cell Tissue Res 2018
15
20

A gut-vascular barrier controls the systemic dissemination of bacteria.
Ilaria Spadoni, Elena Zagato, Alice Bertocchi, Roberta Paolinelli, Edina Hot, Antonio Di Sabatino, Flavio Caprioli, Luca Bottiglieri, Amanda Oldani, Giuseppe Viale,[...]. Science 2015
249
20

Altered intestinal tight junctions' expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability.
Stelios F Assimakopoulos, Athanassios C Tsamandas, Georgios I Tsiaoussis, Elli Karatza, Christos Triantos, Constantine E Vagianos, Iris Spiliopoulou, Valeria Kaltezioti, Aristidis Charonis, Vassiliki N Nikolopoulou,[...]. Eur J Clin Invest 2012
98
20

Detection of functional matrix metalloproteinases by zymography.
Xueyou Hu, Christine Beeton. J Vis Exp 2010
92
20

Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex.
Ning Zheng, Brenda A Schulman, Langzhou Song, Julie J Miller, Philip D Jeffrey, Ping Wang, Claire Chu, Deanna M Koepp, Stephen J Elledge, Michele Pagano,[...]. Nature 2002
20

Cleavage of transmembrane junction proteins and their role in regulating epithelial homeostasis.
Porfirio Nava, Ryuta Kamekura, Asma Nusrat. Tissue Barriers 2013
31
20

Proteases and protease inhibitors in infectious diseases.
Ayodeji A Agbowuro, Wilhelmina M Huston, Allan B Gamble, Joel D A Tyndall. Med Res Rev 2018
71
20

Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis.
Malin E V Johansson, Jenny K Gustafsson, Jessica Holmén-Larsson, Karolina S Jabbar, Lijun Xia, Hua Xu, Fayez K Ghishan, Frederic A Carvalho, Andrew T Gewirtz, Henrik Sjövall,[...]. Gut 2014
502
20



TNF-alpha activates MUC2 transcription via NF-kappaB but inhibits via JNK activation.
Dae-ho Ahn, Suzanne C Crawley, Ryota Hokari, Shingo Kato, Stacey C Yang, Jian-Dong Li, Young S Kim. Cell Physiol Biochem 2005
61
20

Phase I study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusions.
V M Macaulay, K J O'Byrne, M P Saunders, J P Braybrooke, L Long, F Gleeson, C S Mason, A L Harris, P Brown, D C Talbot. Clin Cancer Res 1999
124
20

The gut-liver axis in liver disease: Pathophysiological basis for therapy.
Agustín Albillos, Andrea de Gottardi, María Rescigno. J Hepatol 2020
308
20

Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosis.
Javier Fernández, Juan Acevedo, Reiner Wiest, Thierry Gustot, Alex Amoros, Carme Deulofeu, Enric Reverter, Javier Martínez, Faouzi Saliba, Rajiv Jalan,[...]. Gut 2018
236
20

Targeting the gut-liver-immune axis to treat cirrhosis.
Thomas Henry Tranah, Lindsey A Edwards, Bernd Schnabl, Debbie Lindsay Shawcross. Gut 2021
30
20

Targeting the gut-liver axis in liver disease.
Reiner Wiest, Agustin Albillos, Michael Trauner, Jasmohan S Bajaj, Rajiv Jalan. J Hepatol 2017
191
20

Proton pump inhibitors alter the composition of the gut microbiota.
Matthew A Jackson, Julia K Goodrich, Maria-Emanuela Maxan, Daniel E Freedberg, Julian A Abrams, Angela C Poole, Jessica L Sutter, Daphne Welter, Ruth E Ley, Jordana T Bell,[...]. Gut 2016
413
20

Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascites.
Philipp Schwabl, Theresa Bucsics, Kathrin Soucek, Mattias Mandorfer, Simona Bota, Alexander Blacky, Alexander M Hirschl, Arnulf Ferlitsch, Michael Trauner, Markus Peck-Radosavljevic,[...]. Liver Int 2015
54
20

Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets.
Lynn Bedford, James Lowe, Lawrence R Dick, R John Mayer, James E Brownell. Nat Rev Drug Discov 2011
368
20


Biochemical and structural studies of a HECT-like ubiquitin ligase from Escherichia coli O157:H7.
David Yin-wei Lin, Jianbo Diao, Daoguo Zhou, Jue Chen. J Biol Chem 2011
55
20


Guidelines on the management of ascites in cirrhosis.
Guruprasad P Aithal, Naaventhan Palaniyappan, Louise China, Suvi Härmälä, Lucia Macken, Jennifer M Ryan, Emilie A Wilkes, Kevin Moore, Joanna A Leithead, Peter C Hayes,[...]. Gut 2021
46
20

Bacteria-host relationship: ubiquitin ligases as weapons of invasion.
Timurs Maculins, Evgenij Fiskin, Sagar Bhogaraju, Ivan Dikic. Cell Res 2016
65
20

The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria.
Malin E V Johansson, Mia Phillipson, Joel Petersson, Anna Velcich, Lena Holm, Gunnar C Hansson. Proc Natl Acad Sci U S A 2008
20

Occludin: one protein, many forms.
Philip M Cummins. Mol Cell Biol 2012
226
20

Contribution of the Intestinal Microbiome and Gut Barrier to Hepatic Disorders.
Daniel M Chopyk, Arash Grakoui. Gastroenterology 2020
71
20

Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection.
Maria Van der Sluis, Barbara A E De Koning, Adrianus C J M De Bruijn, Anna Velcich, Jules P P Meijerink, Johannes B Van Goudoever, Hans A Büller, Jan Dekker, Isabelle Van Seuningen, Ingrid B Renes,[...]. Gastroenterology 2006
935
20

Colorectal cancer in mice genetically deficient in the mucin Muc2.
Anna Velcich, WanCai Yang, Joerg Heyer, Alessandra Fragale, Courtney Nicholas, Stephanie Viani, Raju Kucherlapati, Martin Lipkin, Kan Yang, Leonard Augenlicht. Science 2002
653
20

Spontaneous bacterial peritonitis in patients with cirrhosis: incidence, outcomes, and treatment strategies.
Sebastián Marciano, Juan Manuel Díaz, Melisa Dirchwolf, Adrián Gadano. Hepat Med 2019
24
20

Publisher Correction: The gut-liver axis and the intersection with the microbiome.
Anupriya Tripathi, Justine Debelius, David A Brenner, Michael Karin, Rohit Loomba, Bernd Schnabl, Rob Knight. Nat Rev Gastroenterol Hepatol 2018
18
20


Proteasome, a Promising Therapeutic Target for Multiple Diseases Beyond Cancer.
Yu Cao, Huajian Zhu, Ruoyu He, Limin Kong, Jiaan Shao, Rangxiao Zhuang, Jianjun Xi, Jiankang Zhang. Drug Des Devel Ther 2020
9
20

Epidemiology and Effects of Bacterial Infections in Patients With Cirrhosis Worldwide.
Salvatore Piano, Virendra Singh, Paolo Caraceni, Rakhi Maiwall, Carlo Alessandria, Javier Fernandez, Elza Cotrim Soares, Dong Joon Kim, Sung Eun Kim, Monica Marino,[...]. Gastroenterology 2019
141
20

Constitutive immune mechanisms: mediators of host defence and immune regulation.
Søren R Paludan, Thomas Pradeu, Seth L Masters, Trine H Mogensen. Nat Rev Immunol 2021
46
20

Forming a mucus barrier along the colon.
George M H Birchenough, Malin E V Johansson. Science 2020
7
20

Pathological bacterial translocation in liver cirrhosis.
Reiner Wiest, Melissa Lawson, Markus Geuking. J Hepatol 2014
426
20

Caco-2 and LS174T cell lines provide different models for studying mucin expression in colon cancer.
Xiao-Dong Bu, Nan Li, Xiao-Qiang Tian, Pei-Lin Huang. Tissue Cell 2011
55
20

Characterization of fecal microbial communities in patients with liver cirrhosis.
Yanfei Chen, Fengling Yang, Haifeng Lu, Baohong Wang, Yunbo Chen, Dajiang Lei, Yuezhu Wang, Baoli Zhu, Lanjuan Li. Hepatology 2011
572
20

FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis.
Marcel Sorribas, Manuel O Jakob, Bahtiyar Yilmaz, Hai Li, David Stutz, Yannik Noser, Andrea de Gottardi, Sheida Moghadamrad, Moshin Hassan, Agustin Albillos,[...]. J Hepatol 2019
70
20

The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system.
Thaher Pelaseyed, Joakim H Bergström, Jenny K Gustafsson, Anna Ermund, George M H Birchenough, André Schütte, Sjoerd van der Post, Frida Svensson, Ana M Rodríguez-Piñeiro, Elisabeth E L Nyström,[...]. Immunol Rev 2014
526
20


The gut-liver axis and the intersection with the microbiome.
Anupriya Tripathi, Justine Debelius, David A Brenner, Michael Karin, Rohit Loomba, Bernd Schnabl, Rob Knight. Nat Rev Gastroenterol Hepatol 2018
454
20


Comparative study of the intestinal mucus barrier in normal and inflamed colon.
Alexander Swidsinski, Vera Loening-Baucke, Franz Theissig, Holger Engelhardt, Stig Bengmark, Stefan Koch, Herbert Lochs, Yvonne Dörffel. Gut 2007
233
20

Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe.
Javier Fernández, Verónica Prado, Jonel Trebicka, Alex Amoros, Thierry Gustot, Reiner Wiest, Carme Deulofeu, Elisabet Garcia, Juan Acevedo, Valentin Fuhrmann,[...]. J Hepatol 2019
110
20

Meta-analysis: proton pump inhibitors moderately increase the risk of small intestinal bacterial overgrowth.
Tingting Su, Sanchuan Lai, Allen Lee, Xingkang He, Shujie Chen. J Gastroenterol 2018
69
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.